Correlation Between Syndax Pharmaceuticals and Vaxcyte

Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Syndax Pharmaceuticals and Vaxcyte, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Vaxcyte.

Diversification Opportunities for Syndax Pharmaceuticals and Vaxcyte

0.17

Correlation Coefficient

Syndax Pharmaceuticals  Vaxcyte

Average diversification

The 3 months correlation between Syndax and Vaxcyte is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Vaxcyte go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Vaxcyte

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 1.02 times more return on investment than Vaxcyte. However, Syndax Pharmaceuticals is 1.02 times more volatile than Vaxcyte. It trades about 0.06 of its potential returns per unit of risk. Vaxcyte is currently generating about -0.06 per unit of risk. If you would invest  1,252  in Syndax Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  104.00  from holding Syndax Pharmaceuticals or generate 8.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Syndax Pharmaceuticals  vs.  Vaxcyte

Syndax Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Syndax Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, Syndax Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Vaxcyte

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Syndax Pharmaceuticals and Vaxcyte

The main advantage of trading using opposite Syndax Pharmaceuticals and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.

The idea behind Syndax Pharmaceuticals and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.